Jason D. Huber - Publications

West Virginia University, Morgantown, WV, United States 
Pharmacology, Neuroscience Biology

57 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Hernandez A, Tan C, Plattner F, Logsdon AF, Pozo K, Yousuf MA, Singh T, Turner RC, Luke-Wold BP, Huber JD, Rosen CL, Bibb JA. Exposure to mild blast forces induces neuropathological effects, neurophysiological deficits and biochemical changes. Molecular Brain. 11: 64. PMID 30409147 DOI: 10.1186/s13041-018-0408-1  0.44
2017 Gao F, Lucke-Wold BP, Li X, Logsdon AF, Xu LC, Xu S, LaPenna KB, Wang H, Talukder MAH, Siedlecki CA, Huber JD, Rosen CL, He P. Reduction of Endothelial Nitric Oxide Increases the Adhesiveness of Constitutive Endothelial Membrane ICAM-1 through Src-Mediated Phosphorylation. Frontiers in Physiology. 8: 1124. PMID 29367846 DOI: 10.3389/fphys.2017.01124  0.44
2017 Logsdon AF, Lucke-Wold BP, Turner RC, Li X, Adkins CE, Mohammad AS, Huber JD, Rosen CL, Lockman PR. A mouse Model of Focal Vascular Injury Induces Astrocyte Reactivity, Tau Oligomers, and Aberrant Behavior. Archives of Neuroscience. 4. PMID 28758136  0.44
2017 Turner RC, Naser ZJ, Lucke-Wold BP, Logsdon AF, Vangilder RL, Matsumoto RR, Huber JD, Rosen CL. Single low-dose lipopolysaccharide preconditioning: neuroprotective against axonal injury and modulates glial cells. Neuroimmunology and Neuroinflammation. 4: 6-15. PMID 28164149 DOI: 10.20517/2347-8659.2016.40  0.92
2017 Lucke-Wold BP, Logsdon A, Turner RC, Huber JD, Rosen CL. Endoplasmic Reticulum Stress Modulation as a Target for Ameliorating Effects of Blast Induced Traumatic Brain Injury. Journal of Neurotrauma. PMID 28077004 DOI: 10.1089/neu.2016.4680  0.44
2016 Turner RC, DiPasquale K, Logsdon AF, Tan Z, Naser ZJ, Huber JD, Rosen CL, Lucke-Wold BP. The role for infarct volume as a surrogate measure of functional outcome following ischemic stroke. Journal of Systems and Integrative Neuroscience. 2. PMID 28299202  0.44
2016 Lucke-Wold BP, Phillips M, Turner RC, Logsdon AF, Smith KE, Huber JD, Rosen CL, Regele JD. Elucidating the role of compression waves and impact duration for generating mild traumatic brain injury in rats. Brain Injury. 1-8. PMID 27880054 DOI: 10.1080/02699052.2016.1218547  0.44
2016 Nguyen L, Lucke-Wold BP, Logsdon AF, Scandinaro AL, Huber JD, Matsumoto RR. Behavioral and biochemical effects of ketamine and dextromethorphan relative to its antidepressant-like effects in Swiss Webster mice. Neuroreport. 27: 1004-11. PMID 27580401 DOI: 10.1097/WNR.0000000000000646  0.52
2016 Logsdon AF, Lucke-Wold BP, Nguyen L, Matsumoto RR, Turner RC, Rosen CL, Huber JD. Salubrinal reduces oxidative stress, neuroinflammation and impulsive-like behavior in a rodent model of traumatic brain injury. Brain Research. PMID 27131989 DOI: 10.1016/j.brainres.2016.04.063  0.44
2016 Lucke-Wold BP, Logsdon AF, Manoranjan B, Turner RC, McConnell E, Vates GE, Huber JD, Rosen CL, Simard JM. Aneurysmal Subarachnoid Hemorrhage and Neuroinflammation: A Comprehensive Review. International Journal of Molecular Sciences. 17. PMID 27049383 DOI: 10.3390/ijms17040497  0.44
2015 Turner RC, Lucke-Wold BP, Logsdon AF, Robson MJ, Lee JM, Bailes JE, Dashnaw ML, Huber JD, Petraglia AL, Rosen CL. Modeling Chronic Traumatic Encephalopathy: The Way Forward for Future Discovery. Frontiers in Neurology. 6: 223. PMID 26579067 DOI: 10.3389/fneur.2015.00223  0.52
2015 Turner RC, Lucke-Wold BP, Logsdon AF, Robson MJ, Dashnaw ML, Huang JH, Smith KE, Huber JD, Rosen CL, Petraglia AL. The Quest to Model Chronic Traumatic Encephalopathy: A Multiple Model and Injury Paradigm Experience. Frontiers in Neurology. 6: 222. PMID 26539159 DOI: 10.3389/fneur.2015.00222  0.52
2015 Lucke-Wold BP, Nguyen L, Turner RC, Logsdon AF, Chen YW, Smith KE, Huber JD, Matsumoto R, Rosen CL, Tucker ES, Richter E. Traumatic brain injury and epilepsy: Underlying mechanisms leading to seizure. Seizure. 33: 13-23. PMID 26519659 DOI: 10.1016/j.seizure.2015.10.002  0.52
2015 Lucke-Wold BP, Naser ZJ, Logsdon AF, Turner RC, Smith KE, Robson MJ, Bailes JE, Lee JM, Rosen CL, Huber JD. Amelioration of nicotinamide adenine dinucleotide phosphate-mediated stress reduces cell death after blast-induced traumatic brain injury. Translational Research : the Journal of Laboratory and Clinical Medicine. PMID 26414010 DOI: 10.1016/j.trsl.2015.08.005  0.52
2015 Lucke-Wold BP, Turner RC, Logsdon AF, Nguyen L, Bailes JE, Lee JM, Robson MJ, Omalu BI, Huber JD, Rosen CL. Endoplasmic reticulum stress implicated in chronic traumatic encephalopathy. Journal of Neurosurgery. 1-16. PMID 26381255 DOI: 10.3171/2015.3.JNS141802  0.44
2015 Tan Z, Lucke-Wold BP, Logsdon AF, Turner RC, Tan C, Li X, Hongpaison J, Alkon DL, Simpkins JW, Rosen CL, Huber JD. Bryostatin extends tPA time window to 6h following middle cerebral artery occlusion in aged female rats. European Journal of Pharmacology. 764: 404-412. PMID 26189021 DOI: 10.1016/j.ejphar.2015.07.035  0.44
2015 Logsdon AF, Lucke-Wold BP, Turner RC, Huber JD, Rosen CL, Simpkins JW. Role of Microvascular Disruption in Brain Damage from Traumatic Brain Injury. Comprehensive Physiology. 5: 1147-60. PMID 26140712 DOI: 10.1002/cphy.c140057  0.44
2015 Lucke-Wold BP, Smith KE, Nguyen L, Turner RC, Logsdon AF, Jackson GJ, Huber JD, Rosen CL, Miller DB. Sleep disruption and the sequelae associated with traumatic brain injury. Neuroscience and Biobehavioral Reviews. 55: 68-77. PMID 25956251 DOI: 10.1016/j.neubiorev.2015.04.010  0.52
2015 Lucke-Wold BP, Turner RC, Logsdon AF, Simpkins JW, Alkon DL, Smith KE, Chen YW, Tan Z, Huber JD, Rosen CL. Common mechanisms of Alzheimer's disease and ischemic stroke: the role of protein kinase C in the progression of age-related neurodegeneration. Journal of Alzheimer's Disease : Jad. 43: 711-24. PMID 25114088 DOI: 10.3233/JAD-141422  0.52
2014 VanGilder RL, Huber JD. Sesamol: a Treatment for Diabetes-Associated Blood-Brain Barrier Dysfunction. Postdoc Journal : a Journal of Postdoctoral Research and Postdoctoral Affairs. 2: 13-22. PMID 28781979  0.92
2014 Lucke-Wold BP, DiPasquale K, Logsdon AF, Nguyen L, Lucke-Wold AN, Turner RC, Huber JD, Rosen CL. Metabolic Syndrome and its Profound Effect on Prevalence of Ischemic Stroke. American Medical Student Research Journal. 1: 29-38. PMID 27284575 DOI: 10.15422/amsrj.2014.05.004  0.44
2014 Elliott AS, Huber JD, O'Callaghan JP, Rosen CL, Miller DB. A review of sleep deprivation studies evaluating the brain transcriptome. Springerplus. 3: 728. PMID 25932362 DOI: 10.1186/2193-1801-3-728  0.44
2014 Lucke-Wold BP, Logsdon AF, Turner RC, Rosen CL, Huber JD. Aging, the metabolic syndrome, and ischemic stroke: redefining the approach for studying the blood-brain barrier in a complex neurological disease. Advances in Pharmacology (San Diego, Calif.). 71: 411-49. PMID 25307225 DOI: 10.1016/bs.apha.2014.07.001  0.44
2014 Lucke-Wold BP, Logsdon AF, Smith KE, Turner RC, Alkon DL, Tan Z, Naser ZJ, Knotts CM, Huber JD, Rosen CL. Bryostatin-1 Restores Blood Brain Barrier Integrity following Blast-Induced Traumatic Brain Injury. Molecular Neurobiology. PMID 25301233 DOI: 10.1007/s12035-014-8902-7  0.52
2014 Tan Z, Li X, Turner RC, Logsdon AF, Lucke-Wold B, DiPasquale K, Jeong SS, Chen R, Huber JD, Rosen CL. Combination treatment of r-tPA and an optimized human apyrase reduces mortality rate and hemorrhagic transformation 6h after ischemic stroke in aged female rats. European Journal of Pharmacology. 738: 368-73. PMID 24933645 DOI: 10.1016/j.ejphar.2014.05.052  0.52
2014 Meyer DA, Torres-Altoro MI, Tan Z, Tozzi A, Di Filippo M, DiNapoli V, Plattner F, Kansy JW, Benkovic SA, Huber JD, Miller DB, Greengard P, Calabresi P, Rosen CL, Bibb JA. Ischemic stroke injury is mediated by aberrant Cdk5. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 8259-67. PMID 24920629 DOI: 10.1523/JNEUROSCI.4368-13.2014  0.52
2014 Robson MJ, Turner RC, Naser ZJ, McCurdy CR, O'Callaghan JP, Huber JD, Matsumoto RR. SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation. Experimental Neurology. 254: 180-9. PMID 24508558 DOI: 10.1016/j.expneurol.2014.01.020  0.52
2014 Turner RC, VanGilder RL, Naser ZJ, Lucke-Wold BP, Bailes JE, Matsumoto RR, Huber JD, Rosen CL. Elucidating the severity of preclinical traumatic brain injury models: a role for functional assessment? Neurosurgery. 74: 382-94; discussion 3. PMID 24448183 DOI: 10.1227/NEU.0000000000000292  0.52
2014 VanGilder RL, Davidov DM, Stinehart KR, Huber JD, Turner RC, Wilson KS, Haney E, Davis SM, Chantler PD, Theeke L, Rosen CL, Crocco TJ, Gutmann L, Barr TL. C-reactive protein and long-term ischemic stroke prognosis. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 21: 547-53. PMID 24211144 DOI: 10.1016/j.jocn.2013.06.015  0.52
2013 Tan Z, Turner RC, Leon RL, Li X, Hongpaisan J, Zheng W, Logsdon AF, Naser ZJ, Alkon DL, Rosen CL, Huber JD. Bryostatin improves survival and reduces ischemic brain injury in aged rats after acute ischemic stroke. Stroke; a Journal of Cerebral Circulation. 44: 3490-7. PMID 24172582 DOI: 10.1161/STROKEAHA.113.002411  0.52
2013 Turner RC, Naser ZJ, Logsdon AF, DiPasquale KH, Jackson GJ, Robson MJ, Gettens RT, Matsumoto RR, Huber JD, Rosen CL. Modeling clinically relevant blast parameters based on scaling principles produces functional & histological deficits in rats. Experimental Neurology. 248: 520-9. PMID 23876514 DOI: 10.1016/j.expneurol.2013.07.008  0.52
2013 Robson MJ, Turner RC, Naser ZJ, McCurdy CR, Huber JD, Matsumoto RR. SN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulation. Experimental Neurology. 247: 134-42. PMID 23631864 DOI: 10.1016/j.expneurol.2013.04.009  0.52
2013 Turner RC, Lucke-Wold B, Lucke-Wold N, Elliott AS, Logsdon AF, Rosen CL, Huber JD. Neuroprotection for ischemic stroke: moving past shortcomings and identifying promising directions. International Journal of Molecular Sciences. 14: 1890-917. PMID 23344061 DOI: 10.3390/ijms14011890  0.44
2013 Turner RC, Dodson SC, Rosen CL, Huber JD. The science of cerebral ischemia and the quest for neuroprotection: navigating past failure to future success. Journal of Neurosurgery. 118: 1072-85. PMID 23331000 DOI: 10.3171/2012.11.JNS12408  0.44
2012 Lucke-Wold BP, Turner RC, Lucke-Wold AN, Rosen CL, Huber JD. Age and the metabolic syndrome as risk factors for ischemic stroke: improving preclinical models of ischemic stroke. The Yale Journal of Biology and Medicine. 85: 523-39. PMID 23239952  0.44
2012 Turner RC, Seminerio MJ, Naser ZJ, Ford JN, Martin SJ, Matsumoto RR, Rosen CL, Huber JD. Effects of aging on behavioral assessment performance: implications for clinically relevant models of neurological disease. Journal of Neurosurgery. 117: 629-37. PMID 22746378 DOI: 10.3171/2012.5.JNS112224  0.52
2012 Leon RL, Li X, Huber JD, Rosen CL. Worsened outcome from middle cerebral artery occlusion in aged rats receiving 17β-estradiol. Endocrinology. 153: 3386-93. PMID 22581460 DOI: 10.1210/en.2011-1859  0.44
2012 VanGilder RL, Huber JD, Rosen CL, Barr TL. The transcriptome of cerebral ischemia. Brain Research Bulletin. 88: 313-9. PMID 22381515 DOI: 10.1016/j.brainresbull.2012.02.002  0.92
2011 Leon RL, Huber JD, Rosen CL. Potential age-dependent effects of estrogen on neural injury. The American Journal of Pathology. 178: 2450-60. PMID 21641373 DOI: 10.1016/j.ajpath.2011.01.057  0.44
2011 Vangilder RL, Rosen CL, Barr TL, Huber JD. Targeting the neurovascular unit for treatment of neurological disorders. Pharmacology & Therapeutics. 130: 239-47. PMID 21172386 DOI: 10.1016/j.pharmthera.2010.12.004  0.92
2011 Seminerio MJ, Kaushal N, Shaikh J, Huber JD, Coop A, Matsumoto RR. Sigma (σ) receptor ligand, AC927 (N-phenethylpiperidine oxalate), attenuates methamphetamine-induced hyperthermia and serotonin damage in mice. Pharmacology, Biochemistry, and Behavior. 98: 12-20. PMID 21130800 DOI: 10.1016/j.pbb.2010.11.023  0.52
2009 Kelly KA, Li X, Tan Z, VanGilder RL, Rosen CL, Huber JD. NOX2 inhibition with apocynin worsens stroke outcome in aged rats. Brain Research. 1292: 165-72. PMID 19635468 DOI: 10.1016/j.brainres.2009.07.052  0.52
2009 VanGilder RL, Kelly KA, Chua MD, Ptachcinski RL, Huber JD. Administration of sesamol improved blood-brain barrier function in streptozotocin-induced diabetic rats. Experimental Brain Research. 197: 23-34. PMID 19565232 DOI: 10.1007/s00221-009-1866-6  0.52
2009 Tan Z, Li X, Kelly KA, Rosen CL, Huber JD. Plasminogen activator inhibitor type 1 derived peptide, EEIIMD, diminishes cortical infarct but fails to improve neurological function in aged rats following middle cerebral artery occlusion. Brain Research. 1281: 84-90. PMID 19465008 DOI: 10.1016/j.brainres.2009.05.042  0.52
2008 DiNapoli VA, Huber JD, Houser K, Li X, Rosen CL. Early disruptions of the blood-brain barrier may contribute to exacerbated neuronal damage and prolonged functional recovery following stroke in aged rats. Neurobiology of Aging. 29: 753-64. PMID 17241702 DOI: 10.1016/j.neurobiolaging.2006.12.007  0.44
2006 Huber JD, VanGilder RL, Houser KA. Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats. American Journal of Physiology. Heart and Circulatory Physiology. 291: H2660-8. PMID 16951046 DOI: 10.1152/ajpheart.00489.2006  0.92
2005 Brooks TA, Hawkins BT, Huber JD, Egleton RD, Davis TP. Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations. American Journal of Physiology. Heart and Circulatory Physiology. 289: H738-43. PMID 15792985 DOI: 10.1152/ajpheart.01288.2004  0.52
2004 Hawkins BT, Abbruscato TJ, Egleton RD, Brown RC, Huber JD, Campos CR, Davis TP. Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution. Brain Research. 1027: 48-58. PMID 15494156 DOI: 10.1016/j.brainres.2004.08.043  0.52
2004 Hau VS, Huber JD, Campos CR, Davis RT, Davis TP. Effect of lambda-carrageenan-induced inflammatory pain on brain uptake of codeine and antinociception. Brain Research. 1018: 257-64. PMID 15276886 DOI: 10.1016/j.brainres.2004.05.081  0.52
2004 Mark KS, Burroughs AR, Brown RC, Huber JD, Davis TP. Nitric oxide mediates hypoxia-induced changes in paracellular permeability of cerebral microvasculature. American Journal of Physiology. Heart and Circulatory Physiology. 286: H174-80. PMID 12958038 DOI: 10.1152/ajpheart.00669.2002  0.52
2003 Wolka AM, Huber JD, Davis TP. Pain and the blood-brain barrier: obstacles to drug delivery. Advanced Drug Delivery Reviews. 55: 987-1006. PMID 12935941 DOI: 10.1016/S0169-409X(03)00100-5  0.52
2003 Huber JD, Campos CR, Egleton RD, Witt K, Guo L, Roberts MJ, Bentley MD, Davis TP. Conjugation of low molecular weight poly(ethylene glycol) to biphalin enhances antinociceptive profile. Journal of Pharmaceutical Sciences. 92: 1377-85. PMID 12820142 DOI: 10.1002/jps.10406  0.52
2003 Egleton RD, Campos CC, Huber JD, Brown RC, Davis TP. Differential effects of diabetes on rat choroid plexus ion transporter expression. Diabetes. 52: 1496-501. PMID 12765962 DOI: 10.2337/diabetes.52.6.1496  0.52
2003 Brown RC, Mark KS, Egleton RD, Huber JD, Burroughs AR, Davis TP. Protection against hypoxia-induced increase in blood-brain barrier permeability: role of tight junction proteins and NFkappaB. Journal of Cell Science. 116: 693-700. PMID 12538770 DOI: 10.1242/jcs.00264  0.52
2002 Witt KA, Huber JD, Egleton RD, Davis TP. Pluronic p85 block copolymer enhances opioid peptide analgesia. The Journal of Pharmacology and Experimental Therapeutics. 303: 760-7. PMID 12388663 DOI: 10.1124/jpet.102.039545  0.52
2002 Hau VS, Huber JD, Campos CR, Lipkowski AW, Misicka A, Davis TP. Effect of guanidino modification and proline substitution on the in vitro stability and blood-brain barrier permeability of endomorphin II. Journal of Pharmaceutical Sciences. 91: 2140-9. PMID 12226841 DOI: 10.1002/jps.10202  0.52
2002 Huber JD, Hau VS, Mark KS, Brown RC, Campos CR, Davis TP. Viability of microvascular endothelial cells to direct exposure of formalin, lambda-carrageenan, and complete Freund's adjuvant. European Journal of Pharmacology. 450: 297-304. PMID 12208323 DOI: 10.1016/S0014-2999(02)02150-7  0.52
Show low-probability matches.